BAFF selectively enhances the survival of plasmablasts generated from human memory B cells
- PMID: 12865416
- PMCID: PMC164292
- DOI: 10.1172/JCI18025
BAFF selectively enhances the survival of plasmablasts generated from human memory B cells
Erratum in
- J Clin Invest. 2004 Apr;113(7):1069
Abstract
The generation of Ig-secreting cells (ISCs) from memory B cells requires interactions between antigen-specific (Ag-specific) B cells, T cells, and dendritic cells. This process must be strictly regulated to ensure sufficient humoral immunity while avoiding production of pathogenic autoantibodies. BAFF, a member of the TNF family, is a key regulator of B cell homeostasis. BAFF exerts its effect by binding to three receptors - transmembrane activator of and CAML interactor (TACI), B cell maturation antigen (BCMA), and BAFF receptor (BAFF-R). To elucidate the contribution of BAFF to the differentiation of B cells into ISCs, we tracked the fate of human memory B cells stimulated with BAFF or CD40L. BAFF and CD40L significantly increased the overall number of surviving B cells. This was achieved via distinct mechanisms. CD40L induced proliferation of nondifferentiated blasts, while BAFF prevented apoptosis of ISCs without enhancing proliferation. The altered responsiveness of activated memory B cells to CD40L and BAFF correlated with changes in surface phenotype such that expression of CD40 and BAFF-R were reduced on ISCs while BCMA was induced. These results suggest BAFF may enhance humoral immunity in vivo by promoting survival of ISCs via a BCMA-dependent mechanism. These findings have wide-ranging implications for the treatment of human immunodeficiencies as well as autoimmune diseases.
Figures
Similar articles
-
B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses.Mol Cell Biol. 2001 Jun;21(12):4067-74. doi: 10.1128/MCB.21.12.4067-4074.2001. Mol Cell Biol. 2001. PMID: 11359913 Free PMC article.
-
Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.Biochemistry. 2005 Feb 15;44(6):1919-31. doi: 10.1021/bi048227k. Biochemistry. 2005. PMID: 15697217
-
Identification of proteoglycans as the APRIL-specific binding partners.J Exp Med. 2005 May 2;201(9):1375-83. doi: 10.1084/jem.20042309. Epub 2005 Apr 25. J Exp Med. 2005. PMID: 15851487 Free PMC article.
-
The BAFF/APRIL system: life beyond B lymphocytes.Mol Immunol. 2005 May;42(7):763-72. doi: 10.1016/j.molimm.2004.06.041. Epub 2004 Dec 8. Mol Immunol. 2005. PMID: 15829264 Review.
-
BAFF, APRIL and their receptors: structure, function and signaling.Semin Immunol. 2006 Oct;18(5):263-75. doi: 10.1016/j.smim.2006.04.006. Epub 2006 Aug 17. Semin Immunol. 2006. PMID: 16914324 Review.
Cited by
-
New concepts in the generation and functions of IgA.Nat Rev Immunol. 2012 Dec;12(12):821-32. doi: 10.1038/nri3322. Epub 2012 Oct 29. Nat Rev Immunol. 2012. PMID: 23103985 Review.
-
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.Arthritis Rheum. 2011 Dec;63(12):3918-30. doi: 10.1002/art.30613. Arthritis Rheum. 2011. PMID: 22127708 Free PMC article. Clinical Trial.
-
B-cell targeted therapeutics in clinical development.Arthritis Res Ther. 2013;15 Suppl 1(Suppl 1):S4. doi: 10.1186/ar3906. Epub 2013 Apr 4. Arthritis Res Ther. 2013. PMID: 23566679 Free PMC article. Review.
-
B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia.Blood. 2006 Apr 1;107(7):2882-8. doi: 10.1182/blood-2005-09-3552. Epub 2005 Nov 22. Blood. 2006. PMID: 16304043 Free PMC article.
-
Expression of BAFF-R (BR 3) in normal and neoplastic lymphoid tissues characterized with a newly developed monoclonal antibody.Virchows Arch. 2005 Jul;447(1):53-60. doi: 10.1007/s00428-005-1275-6. Epub 2005 Jun 14. Virchows Arch. 2005. PMID: 16025281
References
-
- Van Kooten C, Banchereau J. CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv. Immunol. 1996;61:1–77. - PubMed
-
- Liu YJ, Banchereau J. The paths and molecular controls of peripheral B-cell development. The Immunologist. 1996;4:55–66.
-
- Agematsu K, et al. Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27/CD70 interaction. Blood. 1998;91:173–180. - PubMed
-
- Stuber E, Neurath M, Calderhead D, Fell HP, Strober W. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity. 1995;2:507–521. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous